Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802). (Q46103036)
Jump to navigation
Jump to search
scientific article published on 2 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802). |
scientific article published on 2 March 2009 |
Statements
1 reference
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802). (English)
1 reference
N Katsumata
1 reference
T Watanabe
1 reference
H Minami
1 reference
K Aogi
1 reference
T Tabei
1 reference
M Sano
1 reference
N Masuda
1 reference
J Andoh
1 reference
T Ikeda
1 reference
T Shibata
1 reference
S Takashima
1 reference
2 March 2009
1 reference
1 reference
20
1 reference
7
1 reference
1210-1215
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference